- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine
01.1: 9 residues within 4Å:- Chain A: L.113, I.140, R.143, H.144, F.147, L.152, Y.159, R.184, G.187
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Ligand interactions- Hydrophobic interactions: A:I.140, A:F.147, A:L.152, A:R.184
- Metal complexes: A:H.144, 01.1
- 1 x IMN: INDOMETHACIN(Non-covalent)
- 6 x PLM: PALMITIC ACID(Non-covalent)
PLM.3: 5 residues within 4Å:- Chain A: R.115, Y.136, L.137, A.156, Y.159
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:Y.136, A:Y.136, A:Y.136, A:A.156, A:Y.159, A:Y.159
- Water bridges: A:R.115, A:R.115
- Salt bridges: A:R.115
PLM.4: 13 residues within 4Å:- Chain A: V.21, V.44, L.64, L.67, Y.148, P.150, L.248, L.249, A.252, R.255, L.281, L.282, S.285
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:V.21, A:V.44, A:L.64, A:L.67, A:P.150, A:L.248, A:A.252, A:L.282
- Hydrogen bonds: A:Y.148, A:S.285
- Water bridges: A:R.255, A:S.285, A:H.286
- Salt bridges: A:R.255
PLM.5: 14 residues within 4Å:- Chain A: S.340, V.342, R.346, P.382, L.385, I.386, N.389, C.390, Y.409, L.428, C.436, L.451, R.483
- Ligands: PLM.6
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.385, A:I.386, A:I.386, A:L.428
- Hydrogen bonds: A:S.340
- Salt bridges: A:R.346, A:R.483
PLM.6: 12 residues within 4Å:- Chain A: L.385, Y.409, V.416, T.420, L.421, V.424, L.458, H.462, V.471, F.486, S.487
- Ligands: PLM.5
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:Y.409, A:Y.409, A:Y.409, A:Y.409, A:L.421, A:V.424, A:L.458, A:H.462, A:V.471, A:F.486, A:F.486
- Hydrogen bonds: A:Y.409, A:S.487
PLM.7: 12 residues within 4Å:- Chain A: Y.399, N.403, F.500, F.505, K.523, L.530, H.533, V.545, F.549, A.550, S.577, Q.578
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:F.500, A:L.530, A:V.545, A:F.549, A:F.549, A:Q.578
- Salt bridges: A:K.523
PLM.8: 7 residues within 4Å:- Chain A: R.207, K.210, A.211, S.230, D.322, L.345, K.349
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:R.207, A:K.210, A:A.211, A:L.345
- Water bridges: A:R.207
- Salt bridges: A:R.207
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Man, X.Y. et al., Human serum albumin-copper(II) agent-Indomethacin complex. To Be Published
- Release Date
- 2025-03-12
- Peptides
- Albumin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.09 Å
- Oligo State
- monomer
- Ligands
- 1 x 01: ~{N},~{N}-dimethyl-7-propan-2-yl-3-thia-5-aza-1,6-diazonia-2$l^{3}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(12),4,6,8,10-pentaen-4-amine
- 1 x IMN: INDOMETHACIN(Non-covalent)
- 6 x PLM: PALMITIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Man, X.Y. et al., Human serum albumin-copper(II) agent-Indomethacin complex. To Be Published
- Release Date
- 2025-03-12
- Peptides
- Albumin: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A